The increasing prevalence of chronic diseases, rising demand for precise drug delivery, and growing adoption of home healthcare are driving the growth of the infusion pump device market. However, the market also faces several challenges. High device acquisition and maintenance costs, stringent regulatory approval requirements, and concerns related to infusion pump programming errors...

The Europe Medical Drug‑releasing Micropump market was valued at USD 0.35 billion in 2025 and is projected to grow from USD 0·38 billion in 2026 to USD 0·64 billion by 2034, exhibiting a CAGR of 9·3% during the forecast period. A Medical Drug‑releasing Micropump is a miniature infusion device designed for precise, controlled, and continuous drug delivery. These systems...